Revista de la Sociedad Argentina de Diabetes (Nov 2020)

O19 Adequate hyperglycemia management in inmediate post-operative period is associated with less complications in patients who underwent myucardial revascularization surgery

  • María Gabriela Castillo,
  • Andrea Morejón,
  • María Paz Barbier,
  • Mariana Poletti,
  • Jimena Santamaría,
  • Osvaldo Fretes,
  • Marcela Martínez,
  • Carla Musso,
  • María Cristina Faingold

DOI
https://doi.org/10.47196/diab.v54i3Sup.380
Journal volume & issue
Vol. 54, no. 3Sup
pp. 104 – 104

Abstract

Read online

Introduction: Hyperglycemia in hospitalization (glycemia ≥140 mg/dl) is a frequent event during the perioperative period for cardiovascular surgery (CVS), happening in an 80% of patients with diabetes mellitus (DM) and between 12 to 30% in patients without previous DM (inpatient stress hyperglycemia [HGE]), associated with a higher mortality rate. Objective: To describe the frequency of post operatory (PO) complications and their relation to the degree of glycaemic control in patients, adults older than 40 years old, who had undergone myocardial revascularization surgery (MRS), and who followed a standard protocol of glycaemia control during their hospital stay. Materials and Methods: Observational prospective cohort study. It included 80 patients of middle age 71.08 ± 5.66 years, who had undergone MRS between June 2019 and March 2020. On the other hand, it excluded- patients who presented ketoacidosis or hyperosmolar syndrome. The glycaemia was controlled with capillary monitoring. 42.5% was classified as known DM, 7.5% as unknown DM (both considered DM) and 50% as HGE. Additionally, they were divided according to the degree of glycaemic control in the post operatory first 24 hours. 1) optimum: patients with an average glycemia of ≤180 mg/dl and with no hypoglycemia (glycemia ≤70 mg/dl); 2) non – optimum: patients with an average glycemia of >180 mg/dl. Severity and types of post-operative complications were both assessed. A logistic regression model was built among the variables: age, type of hyperglycaemia, surgery duration, glycaemic control, punctuations in the Cardiac Anesthesia Risk Evaluation Score (CARE), EuroSCOREII, Charlson comorbidities, and the presence or absence of PO complications. In order to be included in the multivariate model, variables with p<0.05 were contemplated as significative. The study was approved by the Ethics Committee and the Institutional Review Board.

Keywords